A5016988392- Radiomics and Machine Learning in Medical Imaging
- Viral-associated cancers and disorders
- Medical Imaging Techniques and Applications
- Lymphoma Diagnosis and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Ocular Oncology and Treatments
- Head and Neck Cancer Studies
- Brain Metastases and Treatment
- Radiopharmaceutical Chemistry and Applications
- Colorectal Cancer Treatments and Studies
- Peptidase Inhibition and Analysis
- Ear and Head Tumors
- Neurofibromatosis and Schwannoma Cases
- Glioma Diagnosis and Treatment
- Thyroid Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Meningioma and schwannoma management
- Cancer Diagnosis and Treatment
- Oral health in cancer treatment
- Lanthanide and Transition Metal Complexes
Queen Elizabeth Hospital
2018-2023
18F-FDG PET-CT is commonly used to monitor treatment response in patients with metastatic colorectal cancer (mCRC). With improvement systemic therapy, complete metabolic (CMR) increasingly encountered but its clinical significance undefined. The study examined the long-term outcomes and recurrence patterns these patients.Consecutive mCRC who achieved CMR on during first-line therapy were retrospectively analysed. Measurable non-measurable lesions identified baseline compared Response...
9093 Background: Pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare disease, sharing common histological features with the undifferentiated subtype of nasopharyngeal (NPC), and being under-represented in non-small cell lung cancer trials clinical guidelines. While gemcitabine-based platinum doublet chemotherapy more established 1 st line treatment stage IV there limited evidence for subsequent strategy. Oral capecitabine one active agents metastatic NPC, was observed to have...